Aurobindo Pharma Sees Surge with 4,443 Active Call Contracts at Rs 1,100 Strike

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today, particularly in the options market. The company’s underlying stock, AUROPHARMA, saw significant activity with 4,443 call contracts traded, generating a turnover of approximately Rs 730.65 lakhs. The options have a strike price of Rs 1,100 and are set to expire on August 28, 2025, with an open interest of 1,252 contracts.
In terms of performance, Aurobindo Pharma has outperformed its sector by 1.89%, marking a notable trend with a consecutive gain over the last four days, resulting in a total return of 6.19% during this period. The stock reached an intraday high of Rs 1,113, reflecting a 3.23% increase for the day.

While the stock is currently trading above its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. However, it is worth noting that investor participation has declined, with delivery volume dropping by 65.44% compared to the 5-day average. Despite this, the stock maintains sufficient liquidity for trades around Rs 1.63 crore, indicating a stable trading environment.

In summary, Aurobindo Pharma's recent performance highlights its active status in the market, driven by notable trading volumes and a positive short-term trend.